@paolo_bareng delved into the challenges of designing vaccines for Plasmodium vivax, whose genetic diversity makes it difficult to pin down.
He showed that current vaccine candidates are based on parasites that might not represent the circulating strains very well. #GEM2024
Pretty cool to see how molecular epidemiology directly impacts real world decisions. Kudos to the researchers for delivering such fantastic insights @DoctorBaz @SarahAuburn2#MAM2024@MAMLorne@CIIDIR_Hub
We are thrilled to introduce CIIDIR!
We are a new initiative of the Barwon Health & Deakin University partnership that aims to leverage existing strengths in infectious disease, microbiome & immunology research.
Stay tuned for updates on our work!
#BarwonHealth#Deakin
How do Plasmodium vivax parasites hide from the immune system? 🦠
That's what @paolo_bareng wants to find out, using data in the MalariaGEN Pv datasets.
We caught up with him at @ASTMH#TropMed22:
https://t.co/5UiOC92efm
First ASTMH conference. Absolutely amazing experience to meet and make new friends. @EizoTakashima, it was great to see you and Taka and the rest of Ehime team! See you in Melbourne soon! #ASTMH2022#TropMed22
Our preprint on exploring analytical approaches for multiplex malaria serology in the Philippines is now up! Please check it out and hope you find it interesting~
@AcademicChatter#phdchat#AcademicTwitter#malaria
@paolo_bareng from @Deakin presents recent work describing antigenic diversity and identification of immune selection hotspots of leading #vivax antigen vaccine candidates and sero-surveillance markers
Find out more ➡️ #ICPVR2022 Rapid Fire Talk #407
Our paper on antimalaria drug resistance in the Philippines is finally published! What a great way to end the year. Check it out online: https://t.co/bIbza2SaHW